Expected Return vs Risk-Reward: Why They Are Not the SameThing

Educational research only — not investment advice.

Expected return vs risk reward sounds like the same idea.

It is not.

Both help investors evaluate an opportunity, but they answer different questions.

Expected return asks:
What is the average outcome after considering different probabilities?

Risk-reward asks:
How much could I gain compared with how much I could lose?

Understanding the difference can prevent a very common investing mistake.

What Is Expected Return?

Expected return combines possible outcomes with their probabilities.

Suppose a stock has:

  • 60% chance of gaining 10%
  • 40% chance of losing 5%

The expected return is:

60% × 10% = 6%

40% × -5% = -2%

Expected return:

4%

This does not mean the stock will actually return 4%.

The stock may gain 10%.

It may lose 5%.

Expected return is simply the probability-weighted average outcome.

What Is Risk-Reward?

Risk-reward ignores probability and focuses on the size of the potential gain versus the potential loss.

Suppose a trade could:

gain 12%

or

lose 4%

The potential reward is three times the potential risk.

That is often described as a:

3:1 reward-to-risk ratio

This sounds attractive.

But there is still a missing question:

How likely is the 12% gain?

A good-looking risk-reward ratio can still describe a poor opportunity if the probability of success is very low.

A Simple Example

Consider two trades.

Trade A

Potential gain: 10%
Potential loss: 5%
Chance of gain: 30%

The risk-reward looks good.

But the probability is weak.

Expected return:

30% × 10% = +3%

70% × -5% = -3.5%

Expected return = -0.5%

Trade B

Potential gain: 8%
Potential loss: 5%
Chance of gain: 70%

The risk-reward is smaller.

But:

70% × 8% = +5.6%

30% × -5% = -1.5%

Expected return = +4.1%

Trade B has the weaker headline risk-reward ratio but the stronger expected outcome.

That is why these measures should not be used separately.

Probability Connects the Two

A useful investment framework considers three things:

Probability of gain
How often might the positive outcome occur?

Expected return
What is the average outcome after weighting probabilities?

Risk-reward
How large is the potential upside compared with the downside?

Each provides different information.

Ignoring any one of them can create a misleading picture.

Why Expected Return Is Not a Prediction

Expected return does not tell you exactly what will happen.

Markets are uncertain.

A stock with a positive expected return can still fall sharply.

A stock with a negative expected return can still rally.

Expected return is better understood as:

a way to compare uncertain opportunities using probabilities

rather than a forecast of the next price move.

Why Risk-Reward Still Matters

Expected return can also hide uncomfortable downside.

Imagine an investment has positive expected return because of a small chance of an enormous gain.

But most outcomes involve losses.

Another investment may produce a more balanced distribution.

So investors should also study:

  • probability of profit
  • maximum drawdown
  • volatility
  • tail risk
  • time horizon

No single metric tells the whole story.

A Simple Decision Framework

Before judging an opportunity, ask:

What could I gain?

What could I lose?

How likely is each outcome?

What is the expected return?

How severe are the worst outcomes?

That gives a much more complete view than using a risk-reward ratio alone.

Track Risk and Expected Return With TradingSimuLab

TradingSimuLab’s Risk Simulation tools help users study expected return, probability of gain, downside risk and simulated future price ranges.

This makes it easier to compare the size, probability and risk of possible outcomes rather than relying on one headline number.

For more quantitative market research and educational trading tools, sign up to TradingSimuLab.

TradingSimuLab is for educational and research purposes only and does not provide investment advice.

Continue exploring TradingSimuLab.

  • How to Tell if a Stock Is Trending or Just Moving Sideways

    Educational research only — not investment advice. Good stock trend analysis starts with one simple question: Is the price actually trending—or is it just moving around inside a range? The difference matters. A strategy that works well during a strong trend can perform poorly when a stock is moving sideways. That is why identifying the…

  • The Next EV Metals Squeeze: Could Rising Electric-Car Sales Reignite Lithium, Nickel and Copper?

    Educational research only — not investment advice. Lithium stocks could be entering a new phase as high fuel prices push more consumers toward electric vehicles. Global EV growth still looks modest at first glance. Sales rose only about 4% year over year from January through August 2026. But underneath that headline, the picture is much…

  • The Next EV Metals Squeeze: Could Rising Electric-Car Sales Reignite Lithium, Nickel and Copper?

    Educational research only — not investment advice. Lithium stocks could be entering a new phase as high fuel prices push more consumers toward electric vehicles. Global EV growth still looks modest at first glance. Sales rose only about 4% year over year from January through August 2026. But underneath that headline, the picture is much…

  • PhonePe Goes Global: Can India’s UPI Model Become a Worldwide Fintech Business?

    Educational research only — not investment advice. The PhonePe IPO story is becoming more global. Walmart-backed PhonePe has received in-principle approval from the UAE central bank for two payment licenses, covering retail payments, card schemes and stored-value services. If final approval follows, the UAE would become PhonePe’s first international market. The bigger question is: Can…

  • Novo Nordisk After Wegovy: Can Five New Blockbusters Restart the Growth Story?

    Educational research only — not investment advice. Novo Nordisk stock is entering an important transition. Wegovy and Ozempic turned Novo into one of the world’s largest pharmaceutical companies. Now investors want to know: What comes after semaglutide? Novo says it aims to launch more than five major blockbuster medicines by 2030 and generate over 150…

  • NSE IPO: Could India’s Stock Exchange Become One of 2026’s Biggest Market Debuts?

    Educational research only — not investment advice. The NSE IPO has become one of India’s most closely watched stock-market events of 2026. India’s National Stock Exchange raised about $2.3 billion, while investors submitted more than $10 billion of bids. The IPO was subscribed 5.71 times, showing strong demand ahead of its September 24 trading debut.…

  • AI Shopping Agents Are Coming: Can Banks Stop Fraud Before Agentic Commerce Goes Mainstream?

    Educational research only — not investment advice. AI shopping agents could change online commerce much faster than many consumers expect. Instead of simply recommending a product, an AI agent could: This new model is often called agentic commerce. But banks are warning that it also creates a new question: Who is responsible when the AI…

  • Saudi Aramco’s Gas Pivot: Is Natural Gas Becoming the Gulf’s Next Big Growth Business?

    Educational research only — not investment advice. Saudi Aramco stock is increasingly becoming more than an oil story. Aramco is preparing to create a dedicated natural-gas division as Saudi Arabia expands domestic gas production and builds a larger international LNG business. The company is even considering eventually selling a minority stake in the new gas…

  • AI Investment vs the OilShock: Can the AI Boom Keep the World Economy Growing?

    Educational research only — not investment advice. The global economy in 2026 is being pulled in two very different directions. On one side is a huge AI investment boom. On the other is an energy shock caused by Middle East disruptions and higher oil and gas prices. The OECD now expects global GDP to grow…